The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Apolipoprotein E: Structure-Function Relationships
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We identified Gly145Asp and Arg154Cys in the same J o u r n a l P r e -p r o o f region (amino acids ~ 148 to 168) [47]”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [47]
In the citing paper
“Variants predicted by models to be deleterious or being located near or in the receptor binding region (amino acids ~ 148 to 168) [47] could be suspected to pose ε2-like qualities.”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [47]
In the citing paper
“Additional support comes from the present data, where Gly145Asp and Arg154Cys are located in the receptor binding region (amino acids ≈148 to 168) 28 and display a phenotype similar to the ɛ2‐defining Arg176Cys residue with high apoE levels and seemingly low risk of dementia (no events).”
From APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) · cites this paper as [28]
In the citing paper
“Val254Glu and Arg269Gly are located in the lipid‐binding carboxyl‐terminal domain (amino acids ≈243 to 317). 28 , 42”
From APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) · cites this paper as [28]
In the citing paper
“However, the receptor-binding sites (AA136-150) for lipoprotein receptors such as the low-density lipoprotein receptor (LDLR), lipoprotein-related receptor 1 (LRP1), and heparan sulfate proteoglycans (HSPGs) are located in a region conserved between species (Fig. 1a) [11–14].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“Notably, an HSPG and LDLR binding site in the APOE sequence is conserved in mice (blue boxed area, AA136-150), including arginine 136, which is replaced by serine in the Christchurch (Ch) variant [12, 39].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“However, mAPOE and hAPOE have a conserved LDLR and HSPG binding motif between AA136 to 150 (human numbering) [11, 12, 39], which includes the R136S Christchurch variant.”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“The mature apoE protein consists of 299 amino acids and an 18amino acid signal peptide is removed post-translationally [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“The APOE gene is located on chromosome 19 and consists of four exons [28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“Lipid-free apoE consists of two domains connected by a “hinge region”: the amino-terminal domain (amino acids 1 to 191) contains the receptor-binding function and the carboxyl-terminal domain (~amino acids 225 to 299) contains the lipid-binding function [28,33].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“The low density lipoprotein (LDL) receptor binding region is situated in helix four between amino acids 136 and 150 [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“ApoE2 exhibits a lower affinity to the LDL receptor compared to apoE3: ~1% of the binding activity of apoE3 and apoE4 [28,36].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“Furthermore, apoE and apoB share the sequence with highest affinity for arterial proteoglycans, a key phenomenon for lipoprotein deposition in the arterial wall [28,63].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“ApoE contains two independently folded functional domains; these are a 22-kDa N-terminal domain (residues 1–191) and a 10-kDa C-terminal domain (residues 216–299) linked by a hinge region (18, 19).”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [18]
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Prediction of protein conformation
Chou, P. Y., & Fasman, G. D. (1974) · Biochemistry · doi:10.1021/bi00699a002 · Cited by 3,309
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Research works printed but not linked: 17
- Cassel, 1984, Atherosclerosis (Shannon, Irel.), 52, 203
- Hallman, 1991, Am. J. Hum. Genet., 49, 338
- Havel, 1989, 1, 1129
- Koizumi, 1985, Antherosclerosis (Shannon, Irel.), 58, 175
- Landis, 1987, Am. J. Physiol., 252, G805
- Lund-Katz, 1993, J. Biol. Chem.
- Mahley, 1983, Arch. Pathol. Lab. Med., 107, 393
- Mahley, 1989, 1, 1195
- Mahley, 1983, 4, 151
- Mahley, 1977, Am. J. Pathol., 87, 205
- Mahley, 1983, Biochim. Biophys. Acta., 737, 197, 10.1016/0304-4157(83)90001-1 · DOI
- Mahley, 1989, 1, 1195
- Phillips, 1986, 128, 387
- Srinivasan, 1972, Atherosclerosis (Shannon, Irel.), 16, 95
- Utermann, 1980, Am. J. Hum. Genet., 32, 339
- Weisgraber, 1983, 4, 103
- Yamamura, 1984, Atherosclerosis (Shannon, Irel.), 50, 159
Cited by
Sorted by citations
Items 301–400 of 828
Apoprotein E genotype and the response of serum cholesterol to dietary fat, cholesterol and cafestol
Weggemans, R. M., Zock, P. L., Ordovás, J. M., Pedro‐Botet, J., & Katan, M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00720-6 · Cited by 52
Miwa, Y., Yamada, M., SUNAYAMA, T., Mitsuzumi, H., Tsuzaki, Y., Chaen, H., Mishima, Y., & Kibata, M. (2004) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.50.211 · Cited by 51
Jolivalt, C. G., Leininger‐Muller, B., Drożdż, R., Naskalski, J. W., & Siest, G. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12661-6 · Cited by 52
On the metabolism of apolipoprotein E and the Alzheimer diseases
Roses, A. D. (1995) · Experimental Neurology · doi:10.1016/0014-4886(95)90019-5 · Cited by 52
Estradiol regulation of astroglia and apolipoprotein E: An important role in neuronal regeneration
Struble, R. G., Nathan, B. P., Cady, C., Cheng, X., & McAsey, M. E. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.013 · Cited by 52
Morita, S., Kawabe, M., Sakurai, A., Okuhira, K., Vertut‐Doï, A., Nakano, M., & Handa, T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402035200 · Cited by 51
Xu, Z., Yang, S., Zhao, S., Zheng, C., Li, H., Zhang, Y., Huang, R., Li, M., Gao, Y., Zhang, S., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.014 · Cited by 50
Fan, D., Zheng, Y., Yang, D., & Wang, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208486200 · Cited by 51
Pauw, M. D., Vanloo, B., Weisgraber, K. H., & Rosseneu, M. (1995) · Biochemistry · doi:10.1021/bi00034a030 · Cited by 50
Self-citationSivashanmugam, A., & Wang, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901012200 · Cited by 49
Luo, J., Maréchal, J., Wärmländer, S. K. T. S., Gräslund, A., & Perálvarez‐Marín, A. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000663 · Cited by 51
Campillos, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg435 · Cited by 50
Genetics of menopause-associated diseases
Massart, F., Reginster, J., & Brandi, M. L. (2001) · Maturitas · doi:10.1016/s0378-5122(01)00283-3 · Cited by 53
Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth
Demattos, R. B., Rudel, L. L., & Williams, D. L. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31622-9 · Cited by 48
Perlecan Mediates the Antiproliferative Effect of Apolipoprotein E on Smooth Muscle Cells
Paka, L., Goldberg, I. J., Obunike, J. C., Choi, S. Y., Saxena, U., Goldberg, I. D., & Pillarisetti, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36403 · Cited by 50
Inoue, T., Saniabadi, A. R., Matsunaga, R., Hoshi, K., Yaguchi, I., & Morooka, S. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(98)00098-7 · Cited by 50
Structure, assembly and secretion of lipoproteins
Davis, R. A., & Vance, J. E. (1996) · New comprehensive biochemistry · doi:10.1016/s0167-7306(08)60524-4 · Cited by 50
Chondroitin-4-Sulfate Protects High-Density Lipoprotein against Copper-Dependent Oxidation
Albertini, R., Luca, G. D., Passi, A. G., Moratti, R., & Abuja, P. M. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1150 · Cited by 49
Fisher, C. B., Wang, J., Francis, G. A., Sykes, B. D., Kay, C. M., & Ryan, R. O. (1997) · Biochemistry and Cell Biology · doi:10.1139/bcb-75-1-45 · Cited by 49
Segelke, B. W., Forstner, M., Knapp, M., Trakhanov, S. D., Parkin, S., Newhouse, Y. M., Bellamy, H. D., Weisgraber, K. H., & Rupp, B. (2000) · Protein Science · doi:10.1110/ps.9.5.886 · Cited by 47
Self-citationHinney, A., Albayrak, Ö., Antel, J., Volckmar, A., Sims, R., Chapman, J., Harold, D., Gerrish, A., Heid, I. M., Winkler, T. W., et al. (2014) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32234 · Cited by 46
Apolipoprotein E4 has extensive conformational heterogeneity in lipid-free and lipid-bound forms
Stuchell-Brereton, M. D., Zimmerman, M. I., Miller, J. J., Mallimadugula, U. L., Incicco, J. J., Roy, D., Smith, L. G., Cubuk, J., Baban, B., DeKoster, G. T., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2215371120 · Cited by 48
Phu, T. A., Ng, M., Vu, N. K., Gao, A. S., & Raffaï, R. L. (2023) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12345 · Cited by 54
Proposed mechanism for lipoprotein remodelling in the brain
Yu, C., Youmans, K. L., & LaDu, M. J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.05.001 · Cited by 49
Huang, Y. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390924 · Cited by 53
Kassam, I., Gagnon, F., & Cusimano, M. D. (2015) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-310500 · Cited by 48
Human apoE3 but not apoE4 rescues impaired astrocyte activation in apoE null mice
Ophir, G., Meilin, S., Efrati, M., Chapman, J., Karussis, D., Roses, A. D., & Michaelson, D. M. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00005-0 · Cited by 49
Cellular Catabolism of Lipid Poor Apolipoprotein E via Cell Surface LDL Receptor-Related Protein
Narita, M., Holtzman, D. M., Fagan, A. M., LaDu, M. J., Yu, L., Han, X., Gross, R. W., Bu, G., & Schwartz, A. L. (2002) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a003282 · Cited by 49
A molecular trigger of lipid binding-induced opening of a helix bundle exchangeable apolipoprotein
Narayanaswami, V., Wang, J., Schieve, D., Kay, C. M., & Ryan, R. O. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4366 · Cited by 48
Membrane‐Mimetic Nanocarriers Formed by a Dipalmitoylated Cell‐Penetrating Peptide
Keller, S., Sauer, I., Strauss, H. M., Gast, K., Dathe, M., & Bienert, M. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200500519 · Cited by 47
Sparks, D. L., Scheff, S. W., Liu, H., Landers, T. M., Danner, F., Coyne, C. M., & Hunsaker, J. C. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00008-1 · Cited by 48
Structure of Apolipophorin-III in Discoidal Lipoproteins
Garda, H. A., Arrese, E. L., & Soulages, J. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110089200 · Cited by 47
Modulation of the lipid binding properties of the N‐terminal domain of human apolipoprotein E3
Weers, P. M. M., Narayanaswami, V., & Ryan, R. O. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02282.x · Cited by 47
Structural and functional variations in human apolipoprotein E3 and E4.
Chou, C.-Y., Jen, W.-P., Hsieh, Y.-H., Shiao, M.-S., & Chang, G.-G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511077200 · Cited by 46
Tamamizu‐Kato, S., Wong, J. Y., Jairam, V., Uchida, K., Raussens, V., Kato, H., Ruysschaert, J., & Narayanaswami, V. (2007) · Biochemistry · doi:10.1021/bi700289k · Cited by 46
Moreno, J. A., López‐Miranda, J., Marı́n, C., Gómez, P., Pérez‐Martínez, P., Fuentes, F. J., de la Puebla, R. Á. F., Paniagua, J. A., Ordovás, J. M., & Pérez‐Jiménez, F. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300124-jlr200 · Cited by 46
Xu, P., Schmechel, D. E., Qiu, H.-L., Herbstreith, M. H., Rothrock‐Christian, T., Eyster, M. V., Roses, A. D., & Gilbert, J. R. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0213 · Cited by 49
Harmful Effects of Increased LDLR Expression in Mice With Human APOE*4 But Not APOE*3
Malloy, S. I., Altenburg, M. K., Knouff, C., Lanningham-Foster, L., Parks, J. S., & Maeda, N. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000094963.07902.fb · Cited by 37
Bentley, N. M., LaDu, M. J., Rajan, C., Getz, G. S., & Reardon, C. A. (2002) · Biochemical Journal · doi:10.1042/bj20020207 · Cited by 43
Lecomte, E., Herbeth, B., Paillé, F., Steinmetz, J., Artur, Y., & Siest, G. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.10.1666 · Cited by 45
A multi‐hit hypothesis for an APOE4 ‐dependent pathophysiological state
Steele, O. G., Stuart, A. C., Minkley, L., Shaw, K., Bonnar, O., Anderle, S., Penn, A. C., Rusted, J., Serpell, L., Hall, C., et al. (2022) · European Journal of Neuroscience · doi:10.1111/ejn.15685 · Cited by 44
Mendoza-Barberà, E., Julve, J., Nilsson, S. K., Lõokene, A., Martín-Campos, J. M., Roig, R., Lechuga-Sancho, A. M., Sloan, J. H., Fuentes‐Prior, P., & Blanco‐Vaca, F. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m031195 · Cited by 49
Function and Comorbidities of Apolipoprotein E in Alzheimer′s Disease
Leduc, V., Domenger, D., Beaumont, L. D., Lalonde, D., Jasmin, S. B., & Poirier, J. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/974361 · Cited by 46
Characterization of apolipoprotein A-V structure and mode of plasma triacylglycerol regulation
Mauldin, K., & Ryan, R. O. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328133856c · Cited by 44
Adeosun, S. O., Hou, X., Zheng, B., Stockmeier, C. A., Ou, X., Paul, I. A., Mosley, T. H., Weisgraber, K. H., & Wang, J. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.497909 · Cited by 47
Self-citationApolipoprotein E mimetic peptide, CN ‐105, improves outcomes in ischemic stroke
Tu, T. M., Kolls, B. J., Soderblom, E. J., Cantillana, V., Ferrell, P. D., Moseley, M. A., Wang, H., Dawson, H. N., & Laskowitz, D. T. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.399 · Cited by 45
Effect of Carboxyl-Terminal Truncation on Structure and Lipid Interaction of Human Apolipoprotein E4
Tanaka, M., Vedhachalam, C., Sakamoto, T., Dhanasekaran, P., Phillips, M. C., Lund-Katz, S., & Saito, H. (2006) · Biochemistry · doi:10.1021/bi060023b · Cited by 43
Petkevičienė, J., Smalinskienė, A., Lukšienė, D., Jurėnienė, K., Ramažauskienė, V., Klumbienė, J., & Lesauskaitė, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041525 · Cited by 42
Durliat, M., André, M., & Babin, P. J. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01033.x · Cited by 43
Stratman, N. C., Castle, C. K., Taylor, B. M., Epps, D. E. V., Melchior, G. W., & Carter, D. B. (2005) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2005.06.005 · Cited by 44
Raman, S., Brookhouser, N., & Brafman, D. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104788 · Cited by 41
Sauer, I., Nikolenko, H., Keller, S., Ajaj, K. A., Bienert, M., & Dathe, M. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.03.017 · Cited by 42
Apolipoprotein E allelic influence on human cerebrospinal fluid apolipoproteins
Montine, K. S., Bassett, C. N., Ou, J. J., Markesbery, W. R., Swift, L. L., & Montine, T. J. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33324-1 · Cited by 42
Massimiliano Mirabella, A., Alvarez, R. B., Engel, W. K., Askanas, V., & Weisgraber, K. H. (1996) · Annals of Neurology · doi:10.1002/ana.410400608 · Cited by 42
Self-citationApolipoprotein E Mimetics and Cholesterol-Lowering Properties
Sharifov, O. F., Nayyar, G., Garber, D. W., Handattu, S. P., Mishra, V., Goldberg, D., Anantharamaiah, G. M., & Gupta, H. (2011) · American Journal of Cardiovascular Drugs · doi:10.2165/11594190-000000000-00000 · Cited by 41
Shuvaev, V. V., Fujii, J., Kawasaki, Y., Itoh, H., Hamaoka, R., Barbier, A., Ziegler, O., Siest, G., & Taniguchi, N. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00047-2 · Cited by 41
Haβ, S., Fresser, F., Köchl, S., Beyreuther, K., Utermann, G., & Baier, G. (1998) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)57838-3 · Cited by 41
The Genetics of Alzheimer’s Disease
Chai, C. K. (2007) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317506295655 · Cited by 42
ApoE associated with lipid has a reduced capacity to inhibit β-amyloid fibril formation
Beffert, U., & Poirier, J. (1998) · Neuroreport · doi:10.1097/00001756-199810050-00031 · Cited by 41
Drabe, N., ZundZünd, G., GrunenfelderGrünenfelder, J., Sprenger, M., Hoerstrup, S. P., Bestmann, L., Maly, F. E., & Turina, M. I. (2001) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(01)00842-9 · Cited by 41
Sorci‐Thomas, M. G., Parks, J. S., Kearns, M. W., Pate, G. N., Zhang, C., & Thomas, M. J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37608-2 · Cited by 41
Effects of polymorphism on the microenvironment of the LDL receptor-binding region of human apoE
Lund-Katz, S., Wehrli, S., Zaiou, M., Newhouse, Y., Weisgraber, K. H., & Phillips, M. C. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31612-6 · Cited by 40
Self-citationHepatic uptake and metabolism of phosphatidylcholine associated with high density lipoproteins
Robichaud, J. C., van der Veen, J. N., Yao, Z., Trigatti, B. L., & Vance, D. E. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.02.010 · Cited by 40
Guptill, J. T., Raja, S. M., Boakye‐Agyeman, F., Noveck, R. J., Ramey, S., Tu, T. M., & Laskowitz, D. T. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.853 · Cited by 42
Is ϵ4 the ancestral human apoE allele?
Mahley, R. W., & Rall, S. C. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00081-0 · Cited by 40
ApoE genotype-specific inhibition of apoptosis
DeKroon, R. M., Mihovilovic, M., Goodger, Z. V., Robinette, J. B., Sullivan, P. M., Saunders, A. M., & Strittmatter, W. J. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300097-jlr200 · Cited by 40
Effect of the apolipoprotein A-IV Q360H polymorphism on postprandial plasma triglyceride clearance
Hockey, K. J., Anderson, R. A., Cook, V. R., Hantgan, R. R., & Weinberg, R. B. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31681-3 · Cited by 40
Multi-functional role of apolipoprotein E in neurodegenerative diseases
Islam, S., Noorani, A. A., Sun, Y., Michikawa, M., & Zou, K. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1535280 · Cited by 43
Type III Hyperlipoproteinemia: Still Worth Considering?
Blum, C. B. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.07.007 · Cited by 39
Henry, N., Krammer, E.-M., Stengel, F., Adams, Q., Van Liefferinge, F., Hubin, E., Chaves, R., Efremov, R., Aebersold, R., Vandenbussche, G., et al. (2018) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006165 · Cited by 42
Accumulation of Triglyceride-Rich Lipoprotein in Subjects With Abdominal Obesity
Bard, J., Charles, M.-A. A., Juhan-Vague, I., Vague, P., André, P., Safar, M. E., Fruchart, J., & Eschwège, É. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.21.3.407 · Cited by 39
Pearson, K. J., Saito, H., Woods, S. C., Lund‐Katz, S., Tso, P., Phillips, M. C., & Davidson, W. S. (2004) · Biochemistry · doi:10.1021/bi048978m · Cited by 39
van Barlingen, H. H. J. J., de Jong, H., Erkelens, D. W., & de Bruin, T. W. A. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37573-8 · Cited by 40
Human Low Density Lipoprotein Receptor Fragment
Simmons, T., Newhouse, Y. M., Arnold, K. S., Innerarity, T. L., & Weisgraber, K. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25531 · Cited by 37
Self-citationSeripa, D., Matera, M. G., Daniele, A., Bizzarro, A., Rinaldi, M., Gravina, C., Bisceglia, L., Corbo, R. M., Panza, F., Solfrizzi, V., et al. (2007) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2006.00344.x · Cited by 38
Beckstead, J. A., Block, B. L., Bielicki, J. K., Kay, C. M., Oda, M. N., & Ryan, R. O. (2005) · Biochemistry · doi:10.1021/bi0477135 · Cited by 38
Belinson, H., & Michaelson, D. M. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0218-9 · Cited by 38
In situ AFM studies of astrocyte-secreted apolipoprotein E- and J-containing lipoproteins
Legleiter, J. A., Demattos, R. B., Holtzman, D. M., & Kowalewski, T. (2004) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.05.009 · Cited by 38
LaDu, M. J., Stine, Narita, M., Getz, G. S., Reardon, C. A., & Bu, G. (2006) · Biochemistry · doi:10.1021/bi051765s · Cited by 36
Interaction of an Exchangeable Apolipoprotein with Phospholipid Vesicles and Lipoprotein Particles
Weers, P. M. M., Narayanaswami, V., Kay, C. M., & Ryan, R. O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21804 · Cited by 38
Impact of apolipoprotein E isoforms on sporadic Alzheimer’s disease
Lozupone, M., & Panza, F. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.375316 · Cited by 38
Regulation of Cerebral Cholesterol Metabolism in Alzheimer Disease
Reiss, A. B., & Voloshyna, I. (2012) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e318246d973 · Cited by 38
Khumsupan, P., Ramírez, R., Khumsupan, D., & Narayanaswami, V. (2010) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.09.007 · Cited by 38
Interactions between age and apoE genotype on fasting and postprandial triglycerides levels
Carvalho-Wells, A. L., Jackson, K. G., Gill, R. D., Olano-Martin, E., Lovegrove, J. A., Williams, C. M., & Minihane, A. M. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.06.036 · Cited by 40
Modeling Alzheimer’s disease with human iPS cells: advancements, lessons, and applications
Essayan-Perez, S., Zhou, B., Nabet, A. M., Wernig, M., & Huang, Y. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104503 · Cited by 40
Examination of Lipid-bound Conformation of Apolipoprotein E4 by Pyrene Excimer Fluorescence
Drury, J., & Narayanaswami, V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414019200 · Cited by 37
Overbergh, L., Lorent, K., Torrekens, S., Leuven, F. V., & BERGHE, H. V. D. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41496-8 · Cited by 37
Morita, S. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(02)00365-7 · Cited by 38
Abnormalities of Apolipoprotein E in the Acquired Immunodeficiency Syndrome
Grünfeld, C., Doerrler, W. T., Pang, M., Jensen, P., Weisgraber, K. H., & Feingold, K. R. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4366 · Cited by 37
Self-citationApolipoprotein E and diets: a case of gene-nutrient interaction?
Rubin, J., & Berglund, L. (2002) · Current Opinion in Lipidology · doi:10.1097/00041433-200202000-00005 · Cited by 37
Toms, T. E., Smith, J., Panoulas, V. F., Blackmore, H. L., Douglas, K., & Kitas, G. D. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110683 · Cited by 37
Orientation and mode of lipid-binding interaction of human apolipoprotein E C-terminal domain
Raussens, V., Drury, J., Forte, T. M., Choy, N., Goormaghtigh, E., Ruysschaert, J., & Narayanaswami, V. (2005) · Biochemical Journal · doi:10.1042/bj20041536 · Cited by 35
The role of full-length apoE in clearance of Gram-negative bacteria and their endotoxins
Petruk, G., Elvén, M., Hartman, E., Davoudi, M., Schmidtchen, A., Puthia, M., & Petrlová, J. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100086 · Cited by 33
Passarella, D., Ciampi, S., Liberto, V. D., Zuccarini, M., Ronci, M., Medoro, A., Foderà, E., Frinchi, M., Mignogna, D., Russo, C., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23168921 · Cited by 38
Perugini, M. A., Schuck, P., & Howlett, G. J. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03319.x · Cited by 35
Lipoprotein assembly and function in an evolutionary perspective
HORST, D. J. V. D., & Rodenburg, K. W. (2010) · BioMolecular Concepts · doi:10.1515/bmc.2010.012 · Cited by 32
Effects of apolipoprotein E genotypes on the development of exfoliation syndrome
Yılmaz, A., Tamer, L., Ateş, N. A., Ankaralı, H. Ç., & Değirmenci, U. (2005) · Experimental Eye Research · doi:10.1016/j.exer.2004.12.018 · Cited by 35
Athanasopoulos, T. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.17.2545 · Cited by 35
Pillot, T., Goethals, M., Vanloo, B., Lins, L., Brasseur, R., Vandekerckhove, J. S., & Rosseneu, M. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00650.x · Cited by 35
Askanas, V., Engel, W. K., & Alvarez, R. B. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10908.x · Cited by 35
Metadata
- Authors
- Weisgraber, K. H.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Weisgraber, Karl H.
- Venue
- Advances in Protein Chemistry
- Publisher
- Elsevier
- Published
- 1994
- Volume
- 45
- Pages
- 249-302
- ISSN
- 0065-3233 (ISSN-L)
- OpenAlex
- W98152484
- Cited by
- 830
- References
- 194
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 14 · 2023: 17 · 2022: 12 · 2021: 20 · 2020: 12 · 2019: 13 · 2018: 14 · 2017: 20 · 2016: 18 · 2015: 15 · 2014: 18 · 2013: 23 · 2012: 26
- FWCI
- 89.45
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in protein chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-41633, P01HL041633)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- apolipoprotein E, lipoprotein metabolism, apolipoprotein structure, APOE isoforms, lipid transfer proteins, lipoprotein receptors, triglyceride-rich lipoproteins, reverse cholesterol transport, lipolysis, serum lipoproteins
- MeSH terms
- Amino Acid Sequence, Animals, Apolipoproteins E, Humans, Molecular Sequence Data, Protein Conformation, Structure-Activity Relationship, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
